Keywords lymphocyte to monocyte ratio survival pancreatic adenocarcinoma pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY-NC Introduction In People’s Republic of China, the morbidity and mortality of pancreatic adenocarcinoma show an increasing trend due to changes in dietary composition and habits, and pancreatic adenocarcinoma has been ranked as the seventh most common cancer and the ninth leading cause of cancer-related deaths. 1 Although currently there are several conventional and emerging treatment options available for pancreatic adenoca
← all excerpts
Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.
1
—
—